Research suggest therapy choice is influenced by physicians’ preferences
Tuesday, March 9th, 2010 Posted in Uncategorized | No Comments »New research shows that the kind of treatment received by prostate cancer patients often depends on the type of specialist providing the patient's care. U.S. researchers evaluated data on more than 85,000 Medicare beneficiaries aged 65 and olde. All of them ...
Prostate cancer-specific survival 30 years after radical prostatectomy
Monday, March 8th, 2010 Posted in prostatectomy | No Comments »A recent report at Virginia Mason Medical Center, Seattle, WA, performed an evaluation on 30-year cancer control and survival outcomes after radical prostatectomy in a single center series of patients treated during a 43-year period. The authors conclude that, in this ...
Arc radiotherapy treatments: Breakthrough in image-guided targeting of prostate tumors
Saturday, March 6th, 2010 Posted in radiation therapy | No Comments »Researchers at Stanford University (California, USA) and Aarhus University Hospital (Aarhus, Denmark), partially supported by Varian Medical Systems (NYSE: VAR), have made a breakthrough in image-guided targeting of prostate tumors during arc radiotherapy treatments. The research team has devised a ...
New prostate cancer guidelines can lead to unneeded treatments with unwanted side effects
Friday, March 5th, 2010 Posted in prostate cancer diagnosis | No Comments »The new American Cancer Society guidelines issued Wednesday on prostate cancer screening mean that many men will fight a cascade of decisions, with a growing responsibility for those decisions falling on their shoulders. The new guidelines acknowledge the uncertainties surrounding PSA ...
Biochemical recurrence after prostatectomy and risk of mortality
Thursday, March 4th, 2010 Posted in prostatectomy | No Comments »A scientific report at Harvard Medical School, Boston, Massachusetts, has recently evaluated whether biochemical recurrence as a time-dependent covariate (t) after radical prostatectomy for prostate cancer was associated with the risk of death and whether salvage therapy with radiotherapy and/or hormonal ...
Estrogen may kill prostate cancer
Wednesday, March 3rd, 2010 Posted in hormone therapy | No Comments »The usual way prostate cancer is treated is by withdrawing male hormone testosterone from the patient. The problem is while this kills most of the cells, the few that remain lead to recurrent, incurable disease. Recently, researchers have suggested an unexpected ...
New class of agents in the treatment of prostate cancer.
Tuesday, March 2nd, 2010 Posted in prostate cancer | No Comments »A scientific team proposes the potential of a whole new class of agents in the treatment of prostate cancer. Researchers have reported data suggesting that some selective estrogen receptor-? (ER?) agonists may have efficacy in the treatment of prostate cancer - ...
Metastasis after radical prostatectomy or external beam radiotherapy for
Monday, March 1st, 2010 Posted in prostatectomy, radiation therapy | No Comments »A study at Memorial Sloan-Kettering Cancer Center, New York, assessed the effect of radical prostatectomy and external beam radiotherapy on distant metastases rates in patients with localized prostate cancer treated with radical prostatectomy or external beam radiotherapy at a single ...